Jefferies Group Reiterates “€80.00” Price Target for Sanofi (SAN)

Sanofi (EPA:SAN) has been assigned a €80.00 ($95.24) price objective by analysts at Jefferies Group in a report issued on Tuesday. The brokerage presently has a “neutral” rating on the stock. Jefferies Group’s price target would suggest a potential upside of 9.07% from the stock’s current price.

Several other analysts have also recently commented on SAN. Deutsche Bank set a €96.00 ($114.29) price target on shares of Sanofi and gave the stock a “buy” rating in a research note on Wednesday, October 18th. Citigroup set a €88.00 ($104.76) price target on shares of Sanofi and gave the stock a “neutral” rating in a research note on Friday, October 6th. S&P Global set a €83.00 ($98.81) price target on shares of Sanofi and gave the stock a “neutral” rating in a research note on Friday, November 3rd. Morgan Stanley set a €92.00 ($109.52) price target on shares of Sanofi and gave the stock a “buy” rating in a research note on Friday, October 6th. Finally, Goldman Sachs Group set a €82.00 ($97.62) price target on shares of Sanofi and gave the stock a “neutral” rating in a research note on Tuesday, October 17th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and five have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of €87.06 ($103.65).

Shares of Sanofi (SAN) opened at €73.35 ($87.32) on Tuesday. The company has a market cap of $92,650.00 and a price-to-earnings ratio of 20.32. Sanofi has a one year low of €71.06 ($84.60) and a one year high of €92.97 ($110.68).

COPYRIGHT VIOLATION WARNING: “Jefferies Group Reiterates “€80.00” Price Target for Sanofi (SAN)” was originally reported by Transcript Daily and is the property of of Transcript Daily. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://transcriptdaily.com/2018/01/16/jefferies-group-reiterates-80-00-price-target-for-sanofi-san.html.

Sanofi Company Profile

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.

Analyst Recommendations for Sanofi (EPA:SAN)

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply